Free Trial

Trupanion, Inc. (NASDAQ:TRUP) Receives Average Recommendation of "Hold" from Analysts

Trupanion logo with Finance background

Key Points

  • Trupanion, Inc. has received an average rating of "Hold" from six analysts, with four recommending a hold and two a buy, and a twelve-month price target of $53.80.
  • The company recently reported earnings of $0.22 per share, significantly beating estimates and showing a revenue increase of 12.3% year-over-year.
  • Insider trading activity includes CFO Fawwad Qureshi selling 2,800 shares at $45.56, reflecting a decrease of 30.27% in their position.
  • MarketBeat previews top five stocks to own in November.

Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) has been assigned an average rating of "Hold" from the six analysts that are presently covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $53.80.

A number of analysts recently weighed in on TRUP shares. Weiss Ratings restated a "hold (c-)" rating on shares of Trupanion in a report on Wednesday. Stifel Nicolaus increased their price target on Trupanion from $41.00 to $45.00 and gave the company a "hold" rating in a research report on Friday, August 8th. Cantor Fitzgerald upgraded shares of Trupanion to a "hold" rating in a report on Wednesday, August 13th. Finally, Piper Sandler raised their target price on shares of Trupanion from $62.00 to $67.00 and gave the stock an "overweight" rating in a report on Friday, August 8th.

Check Out Our Latest Research Report on Trupanion

Trupanion Trading Down 0.1%

Shares of TRUP stock opened at $42.28 on Friday. Trupanion has a fifty-two week low of $31.00 and a fifty-two week high of $57.90. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.32. The stock has a 50-day simple moving average of $45.51 and a 200 day simple moving average of $45.35. The stock has a market capitalization of $1.82 billion, a P/E ratio of 162.62 and a beta of 1.83.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The financial services provider reported $0.22 earnings per share for the quarter, beating the consensus estimate of ($0.03) by $0.25. The company had revenue of $353.56 million during the quarter, compared to analyst estimates of $346.73 million. Trupanion had a net margin of 0.81% and a return on equity of 3.31%. The business's revenue for the quarter was up 12.3% on a year-over-year basis. During the same quarter last year, the firm posted ($0.14) EPS. Trupanion has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, sell-side analysts expect that Trupanion will post 0.13 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CFO Fawwad Qureshi sold 2,800 shares of the firm's stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $45.56, for a total value of $127,568.00. Following the completion of the transaction, the chief financial officer owned 6,451 shares of the company's stock, valued at approximately $293,907.56. This trade represents a 30.27% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Darryl Rawlings sold 30,369 shares of the firm's stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $44.70, for a total value of $1,357,494.30. Following the completion of the sale, the director directly owned 1,413,281 shares of the company's stock, valued at approximately $63,173,660.70. This trade represents a 2.10% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 61,761 shares of company stock valued at $2,739,621. Company insiders own 5.42% of the company's stock.

Institutional Trading of Trupanion

Several institutional investors have recently made changes to their positions in TRUP. Wellington Management Group LLP boosted its stake in shares of Trupanion by 13.2% during the 1st quarter. Wellington Management Group LLP now owns 2,491,227 shares of the financial services provider's stock valued at $92,848,000 after buying an additional 290,788 shares during the period. State Street Corp boosted its position in Trupanion by 2.6% during the second quarter. State Street Corp now owns 1,285,419 shares of the financial services provider's stock valued at $71,148,000 after purchasing an additional 32,839 shares during the last quarter. Geode Capital Management LLC boosted its position in Trupanion by 7.0% during the second quarter. Geode Capital Management LLC now owns 860,988 shares of the financial services provider's stock valued at $47,662,000 after purchasing an additional 56,671 shares during the last quarter. Balyasny Asset Management L.P. lifted its holdings in shares of Trupanion by 8.1% during the 2nd quarter. Balyasny Asset Management L.P. now owns 449,106 shares of the financial services provider's stock valued at $24,858,000 after buying an additional 33,650 shares during the last quarter. Finally, Hosking Partners LLP lifted its holdings in shares of Trupanion by 86.9% during the 1st quarter. Hosking Partners LLP now owns 397,656 shares of the financial services provider's stock valued at $14,821,000 after buying an additional 184,936 shares during the last quarter.

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Further Reading

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Trupanion Right Now?

Before you consider Trupanion, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.

While Trupanion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.